{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:47:28Z","timestamp":1783594048149,"version":"3.55.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201308430250"],"award-info":[{"award-number":["201308430250"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI121989"],"award-info":[{"award-number":["R01AI121989"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.vaccine.2018.03.015","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T15:27:21Z","timestamp":1521386841000},"page":"2061-2068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Oral Chlamydia vaccination induces transmucosal protection in the airway"],"prefix":"10.1016","volume":"36","author":[{"given":"Cuiming","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.03.015_b0005","unstructured":"Centers for Disease Control and Prevention C. In: Services USDoHaH, editor. Sexually transmitted disease surveillance, 2016. Atlanta, GA; 2017. <https:\/\/www.cdc.gov\/std\/stats16\/default.htm>."},{"key":"10.1016\/j.vaccine.2018.03.015_b0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4269\/ajtmh.1992.46.552","article-title":"The natural history of endemic trachoma: a longitudinal study","volume":"46","author":"Taylor","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.03.015_b0015","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1167\/iovs.06-0625","article-title":"Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village","volume":"48","author":"West","year":"2007","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.vaccine.2018.03.015_b0020","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1099\/jmm.0.000523","article-title":"Distribution of Chlamydia trachomatis genotypes in neonatal conjunctivitis in Hungary","volume":"66","author":"Balla","year":"2017","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41479-017-0036-z","article-title":"Atypical bacterial pneumonia in the HIV-infected population","volume":"9","author":"Head","year":"2017","journal-title":"Pneumonia (Nathan)"},{"key":"10.1016\/j.vaccine.2018.03.015_b0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12931-017-0584-z","article-title":"Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides","volume":"18","author":"Webley","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.vaccine.2018.03.015_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftu015","article-title":"Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested","volume":"73","author":"Grayston","year":"2015","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.onehlt.2017.02.003","article-title":"An outbreak of psittacosis at a veterinary school demonstrating a novel source of infection","volume":"3","author":"Chan","year":"2017","journal-title":"One Health"},{"key":"10.1016\/j.vaccine.2018.03.015_b0045","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.24.21155","article-title":"Outbreak of psittacosis in a group of women exposed to Chlamydia psittaci-infected chickens","volume":"20","author":"Laroucau","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2018.03.015_b0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.olq.0000148299.14513.11","article-title":"Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum","volume":"32","author":"Shah","year":"2005","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0055","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1128\/iai.62.5.2094-2097.1994","article-title":"Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility","volume":"62","author":"de la Maza","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0060","doi-asserted-by":"crossref","first-page":"e95076","DOI":"10.1371\/journal.pone.0095076","article-title":"Chlamydial induction of hydrosalpinx in 11 strains of mice reveals multiple host mechanisms for preventing upper genital tract pathology","volume":"9","author":"Chen","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.03.015_b0065","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/AOG.0b013e3182519326","article-title":"Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection","volume":"119","author":"Budrys","year":"2012","journal-title":"Obstetr Gynecol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.fertnstert.2011.06.021","article-title":"Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility","volume":"96","author":"Rodgers","year":"2011","journal-title":"Fertil Steril"},{"issue":"494","key":"10.1016\/j.vaccine.2018.03.015_b0075","first-page":"e7","article-title":"Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatis caseinolytic protease P","volume":"203","author":"Rodgers","year":"2010","journal-title":"Am J Obstetr Gynecol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/infdis\/143.1.63","article-title":"A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis","volume":"143","author":"Barron","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0085","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/infdis\/148.6.1101","article-title":"Chlamydia trachomatis-induced salpingitis in mice","volume":"148","author":"Swenson","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/icb.2015.74","article-title":"The contribution of Chlamydia-specific CD8(+) T cells to upper genital tract pathology","volume":"94","author":"Vlcek","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0095","first-page":"980","article-title":"Vaccines for Chlamydia trachomatis infections","volume":"3","author":"de la Maza","year":"2002","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.vaccine.2018.03.015_b0100","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1128\/IAI.70.6.2741-2751.2002","article-title":"Immunity to murine chlamydial genital infection","volume":"70","author":"Morrison","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.micinf.2013.02.001","article-title":"Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator","volume":"15","author":"Lu","year":"2013","journal-title":"Microb Infect\/Institut Pasteur"},{"key":"10.1016\/j.vaccine.2018.03.015_b0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.12248","article-title":"An atypical CD8 T-cell response to Chlamydia muridarum genital tract infections includes T cells that produce interleukin-13","volume":"142","author":"Johnson","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2018.03.015_b0115","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1586\/erv.09.98","article-title":"Chlamydia vaccine candidates and tools for chlamydial antigen discovery","volume":"8","author":"Rockey","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.03.015_b0120","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4049\/jimmunol.0803075","article-title":"A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0125","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4049\/jimmunol.161.3.1439","article-title":"Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection","volume":"161","author":"Yang","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0130","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.182.3.1602","article-title":"Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models","volume":"182","author":"Yu","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0135","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.4049\/jimmunol.180.4.2459","article-title":"Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia","volume":"180","author":"Karunakaran","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0140","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.vaccine.2011.01.031","article-title":"Induction of protection in mice against a respiratory challenge by a vaccine formulated with the Chlamydia major outer membrane protein adjuvanted with IC31(R)","volume":"29","author":"Cheng","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.015_b0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.vaccine.2005.07.104","article-title":"Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection","volume":"24","author":"Skelding","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.015_b0150","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/iai.63.12.4661-4668.1995","article-title":"Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection","volume":"63","author":"Morrison","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0155","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection","volume":"175","author":"Morrison","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2015.02.004","article-title":"A re-evaluation of the role of B cells in protective immunity to Chlamydia infection","volume":"164","author":"Li","year":"2015","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2018.03.015_b0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/jir.2009.0083","article-title":"The contribution of interleukin-12\/interferon-gamma axis in protection against neonatal pulmonary Chlamydia muridarum challenge","volume":"30","author":"Jupelli","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.vaccine.2018.03.015_b0170","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/IAI.67.4.1763-1769.1999","article-title":"Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection","volume":"67","author":"Lu","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0175","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s11250-014-0585-6","article-title":"Prevalence and molecular identification of Chlamydia abortus in commercial dairy goat farms in a hot region in Mexico","volume":"46","author":"Campos-Hernandez","year":"2014","journal-title":"Trop Anim Health Prod"},{"key":"10.1016\/j.vaccine.2018.03.015_b0180","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/OLQ.0000000000000175","article-title":"Cross-sectional study of genital, rectal, and pharyngeal Chlamydia and gonorrhea in women in rural South Africa","volume":"41","author":"Peters","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/OLQ.0000000000000176","article-title":"Prevalence and characteristics of rectal chlamydia and gonorrhea cases among men who have sex with men after the introduction of nucleic acid amplification test screening at 2 Canadian sexually transmitted infection clinics","volume":"41","author":"Gratrix","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0190","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/cid\/ciu831","article-title":"Evidence for increased Chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics","volume":"60","author":"Gratrix","year":"2015","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2018.03.015_b0195","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/0956462415586317","article-title":"Rectal chlamydia infection in women at high risk of chlamydia attending Canberra Sexual Health Centre","volume":"27","author":"Musil","year":"2016","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.vaccine.2018.03.015_b0200","doi-asserted-by":"crossref","first-page":"e0155880","DOI":"10.1371\/journal.pone.0155880","article-title":"The Chlamydia muridarum organisms fail to auto-inoculate the mouse genital tract after colonization in the gastrointestinal tract for 70 days","volume":"11","author":"Wang","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.03.015_b0205","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1128\/IAI.69.3.1832-1840.2001","article-title":"Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae","volume":"69","author":"Igietseme","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0210","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1128\/IAI.67.7.3686-3689.1999","article-title":"Chlamydial colonization of multiple mucosae following infection by any mucosal route","volume":"67","author":"Perry","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0215","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1128\/AAC.01405-13","article-title":"Differential susceptibilities to azithromycin treatment of chlamydial infection in the gastrointestinal tract and cervix","volume":"57","author":"Yeruva","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.03.015_b0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/2049-632X.12052","article-title":"Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection","volume":"68","author":"Yeruva","year":"2013","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0225","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/IAI.00673-15","article-title":"In vivo and ex vivo imaging reveals a long-lasting chlamydial infection in the mouse gastrointestinal tract following genital tract inoculation","volume":"83","author":"Zhang","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0230","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/IAI.00432-16","article-title":"Intravenous inoculation with Chlamydia muridarum leads to a long-lasting infection restricted to the gastrointestinal tract","volume":"84","author":"Dai","year":"2016","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0235","doi-asserted-by":"crossref","first-page":"e0177691","DOI":"10.1371\/journal.pone.0177691","article-title":"The cryptic plasmid is more important for Chlamydia muridarum to colonize the mouse gastrointestinal tract than to infect the genital tract","volume":"12","author":"Shao","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.03.015_b0240","doi-asserted-by":"crossref","unstructured":"Shao L, Zhang T, Liu Q, Wang J, Zhong G. Chlamydia muridarum with mutations in chromosomal genes tc0237 and\/or tc0668 is deficient in colonizing the mouse gastrointestinal tract. Infect Immun 2017;85. http:\/\/doi.org\/10.1128\/IAI.00321-17. Print 2017 Aug. PMID: 28584162.","DOI":"10.1128\/IAI.00321-17"},{"key":"10.1016\/j.vaccine.2018.03.015_b0245","article-title":"Non-pathogenic colonization with Chlamydia in the gastrointestinal tract as oral vaccination for inducing transmucosal protection","author":"Wang","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0250","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/IAI.01171-15","article-title":"The chromosome-encoded hypothetical protein TC0668 is an upper genital tract pathogenicity factor of Chlamydia muridarum","volume":"84","author":"Conrad","year":"2016","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0255","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/JB.01161-13","article-title":"Transformation of Chlamydia muridarum reveals a role for Pgp5 in suppression of plasmid-dependent gene expression","volume":"196","author":"Liu","year":"2014","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0260","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1128\/IAI.02576-14","article-title":"Plasmid-encoded Pgp3 is a major virulence factor for Chlamydia muridarum to induce hydrosalpinx in mice","volume":"82","author":"Liu","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0265","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1128\/IAI.00386-10","article-title":"Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract","volume":"78","author":"Sturdevant","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0270","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1128\/IAI.03158-14","article-title":"In vitro passage selects for Chlamydia muridarum with enhanced infectivity in cultured cells but attenuated pathogenicity in mouse upper genital tract","volume":"83","author":"Chen","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0275","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.187.4.487","article-title":"Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation","volume":"187","author":"Fan","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.03.015_b0280","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1128\/IAI.01543-13","article-title":"Reduced live organism recovery and lack of hydrosalpinx in mice infected with plasmid-free Chlamydia muridarum","volume":"82","author":"Lei","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0285","doi-asserted-by":"crossref","first-page":"e71649","DOI":"10.1371\/journal.pone.0071649","article-title":"Oviduct infection and hydrosalpinx in DBA1\/j mice is induced by intracervical but not intravaginal inoculation with Chlamydia muridarum","volume":"8","author":"Tang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.03.015_b0290","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.1073\/pnas.94.25.13856","article-title":"Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein","volume":"94","author":"Zhong","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.03.015_b0295","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.186.5.673","article-title":"Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro","volume":"186","author":"Zhong","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.03.015_b0300","doi-asserted-by":"crossref","first-page":"e81236","DOI":"10.1371\/journal.pone.0081236","article-title":"Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms","volume":"8","author":"Dukers-Muijrers","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.03.015_b0305","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/OLQ.0b013e31826ae9a2","article-title":"Prevalence and correlates of rectal Chlamydia and gonorrhea among female clients at sexually transmitted disease clinics","volume":"39","author":"Javanbakht","year":"2012","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0310","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/OLQ.0b013e31815c11fe","article-title":"Chlamydia trachomatis reinfection rates among female adolescents seeking rescreening in school-based health centers","volume":"35","author":"Gaydos","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0315","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/sextrans-2015-052115","article-title":"Retesting young STI clinic visitors with urogenital Chlamydia trachomatis infection in the Netherlands; response to a text message reminder and reinfection rates: a prospective study with historical controls","volume":"92","author":"Kampman","year":"2016","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2018.03.015_b0320","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/infdis\/jit094","article-title":"Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection","volume":"207","author":"Geisler","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/AOG.0b013e3182246a83","article-title":"Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials","volume":"118","author":"Xu","year":"2011","journal-title":"Obstetr Gynecol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0330","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/OLQ.0b013e3181a2a933","article-title":"Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature","volume":"36","author":"Hosenfeld","year":"2009","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0335","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/OLQ.0b013e318151497d","article-title":"The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment","volume":"35","author":"Geisler","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0340","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12879-015-1280-6","article-title":"What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion","volume":"15","author":"Dukers-Muijrers","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0345","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.vaccine.2011.10.059","article-title":"Protective immunity against mouse upper genital tract pathology correlates with high IFNgamma but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway","volume":"30","author":"Lu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.015_b0350","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00543-16","article-title":"Update on Chlamydia trachomatis vaccinology","volume":"24","author":"de la Maza","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0355","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/infdis\/jit095","article-title":"Immunity to Chlamydia trachomatis","volume":"207","author":"Brunham","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0360","article-title":"National Institute of Allergy and Infectious Diseases workshop report: \u201cChlamydia vaccines: The way forward\u201d","author":"Zhong","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.015_b0365","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00749-16","article-title":"IFNgamma is required for optimal antibody-mediated immunity against genital Chlamydia infection","author":"Naglak","year":"2016","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0370","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00409-17","article-title":"Neutrophils are central to antibody-mediated protection against genital Chlamydia","volume":"85","author":"Naglak","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0375","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/IAI.01378-15","article-title":"Tissue-resident T cells as the central paradigm of Chlamydia immunity","volume":"84","author":"Johnson","year":"2016","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0380","doi-asserted-by":"crossref","unstructured":"Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, et al. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 2015;348:aaa8205.","DOI":"10.1126\/science.aaa8205"},{"key":"10.1016\/j.vaccine.2018.03.015_b0385","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/jp.2015.115","article-title":"Chlamydia trachomatis IgG3 seropositivity is associated with gastroschisis","volume":"35","author":"Feldkamp","year":"2015","journal-title":"J Perinatol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0390","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.fertnstert.2015.08.022","article-title":"Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes","volume":"104","author":"Steiner","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.vaccine.2018.03.015_b0395","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/IAI.05022-11","article-title":"Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection","volume":"79","author":"Murthy","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0400","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/2049-632X.12032","article-title":"OT-1 mice display minimal upper genital tract pathology following primary intravaginal Chlamydia muridarum infection","volume":"67","author":"Manam","year":"2013","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2018.03.015_b0405","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.4049\/jimmunol.1400120","article-title":"CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques","volume":"192","author":"Olivares-Zavaleta","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0410","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00429-17","article-title":"The genital tract virulence factor pGP3 is essential for Chlamydia muridarum colonization in the gastrointestinal tract","volume":"86","author":"Shao","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0415","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1128\/IAI.01244-13","article-title":"Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection","volume":"82","author":"Rank","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.03.015_b0420","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4161\/19490976.2014.983763","article-title":"Role of secretory IgA in the mucosal sensing of commensal bacteria","volume":"5","author":"Mathias","year":"2014","journal-title":"Gut Microb"},{"key":"10.1016\/j.vaccine.2018.03.015_b0425","first-page":"57","article-title":"Lack of evidence for an association between infection with Chlamydia trachomatis and Crohn's disease, as indicated by micro-immunofluorescence antibody tests","volume":"88","author":"Mardh","year":"1980","journal-title":"Acta Pathol Microbiol Scand B"},{"key":"10.1016\/j.vaccine.2018.03.015_b0430","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0168-1656(95)00094-1","article-title":"Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors","volume":"44","author":"Levine","year":"1996","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2018.03.015_b0435","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJMc1711583","article-title":"Single-dose cholera vaccine in response to an outbreak in Zambia","volume":"378","author":"Ferreras","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.03.015_b0440","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2471\/BLT.16.189241","article-title":"Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia","volume":"96","author":"Poncin","year":"2018","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.03.015_b0445","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13567-018-0509-y","article-title":"Oral immunization with a novel attenuated Salmonella Typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection","volume":"49","author":"Kim","year":"2018","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2018.03.015_b0450","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.vaccine.2010.11.017","article-title":"A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer","volume":"29","author":"Vendrell","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.015_b0455","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cyto.2016.01.002","article-title":"Bacteria and genetically modified bacteria as cancer therapeutics: current advances and challenges","volume":"89","author":"Nallar","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2018.03.015_b0460","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.molmed.2017.05.008","article-title":"The boosting potential of bacteria in cancer immunotherapy","volume":"23","author":"Binder","year":"2017","journal-title":"Trends Mol Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18303517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18303517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:36Z","timestamp":1759400856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18303517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":92,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0264410X18303517"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Chlamydia vaccination induces transmucosal protection in the airway","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}